Literature DB >> 1109322

Analysis of re-entry mechanisms in the three patients with concealed Wolff-Parkinson-White syndrome.

H Neuss, M Schlepper, J Thormann.   

Abstract

Three patients with recurring attacks of supraventricular tachycardia and no electrocardiographic evidence of the Wolff-Parkinson-White syndrome (WPW syndrome) were studied using intracardiac recordings and atrial stimulation. The findings are interpreted as evidence of a concealed WPW syndrome. In all patients there was antegrade block of the anomalous atrioventricular (A-V) pathway while retrograde conduction was unimpaired and allowed the initiation of the observed reciprocating tachycardias. The diagnosis was based on the assumption that the ventricular myocardium was an essential link in the re-entry circuit. The three most important findings to support this assumption are: 1) retrograde conduction time, measured by the Q-A' interval (Q in ECG to atrial echo), and the rate of tachycardia were dependent on the mode of intraventricular conduction: 2) the first Q-A' interval of the tachycardia was independent of the A-H interval (initiation of atrial impulse to first activation of the His bundle) of the initiating premature atrial depolarization (PAD); 3) there was retrograde conduction following a ventricular premature beat during tachycardia at a time when the A-V node and/or the bundle of His would be refractory.

Entities:  

Mesh:

Year:  1975        PMID: 1109322     DOI: 10.1161/01.cir.51.1.75

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Concealed accessory pathways: Historical notes.

Authors:  G H von Knorre; B Ismer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-03

2.  Atrioventricular reciprocal rhythm and chronic reciprocating tachycardia in a newborn infant with concealed Wolff-Parkinson-White syndrome.

Authors:  R J Sung; P Ferrer; O L Garcia; A Castellanos; H Gelband
Journal:  Br Heart J       Date:  1977-07

3.  Atrial pacing at multiple sites in the Wolff-Parkinson-White syndrome.

Authors:  P Denes; C R Wyndham; F Amat-y-Leon; D Wu; R C Dhingra; R H Miller; K M Rosen
Journal:  Br Heart J       Date:  1977-05

4.  20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits.

Authors:  S R Lalani; J V Thakuria; G F Cox; X Wang; W Bi; M S Bray; C Shaw; S W Cheung; A C Chinault; B A Boggs; Z Ou; E K Brundage; J R Lupski; J Gentile; S Waisbren; A Pursley; L Ma; M Khajavi; G Zapata; R Friedman; J J Kim; J A Towbin; P Stankiewicz; S Schnittger; I Hansmann; T Ai; S Sood; X H Wehrens; J F Martin; J W Belmont; L Potocki
Journal:  J Med Genet       Date:  2008-09-23       Impact factor: 6.318

5.  Effect on paroxysmal re-entrant supraventricular tachycardia of a drug affecting calcium transport (Ro 11-1781).

Authors:  R Gmeiner; C K Ng; M Gstöttner
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

6.  Non-invasive three-dimensional localisation of arrhythmogenic foci in Wolff-Parkinson-White syndrome and in ventricular tachycardia by radionuclide ventriculography: phase analysis of double-angulated integrated single photon emission computed tomography (SPECT).

Authors:  P Weismüller; M Clausen; R Weller; P Richter; J Steinmann; E Henze; I Dormehl; M Kochs; W E Adam; V Hombach
Journal:  Br Heart J       Date:  1993-03

7.  Effects of alternating cycle lengths on refractoriness of the His-Purkinje system.

Authors:  S Denker; M Lehmann; R Mahmud; C Gilbert; M Akhtar
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

8.  Re-entrant tachycardia using two bypass tracts and excluding AV node in short PR interval, normal QRS syndrome.

Authors:  D E Ward; A J Camm; R A Spurrell
Journal:  Br Heart J       Date:  1978-10

9.  Atrial Fibrillation in a Patient With an Accessory Pathway.

Authors:  Andrew Silverman; Sonia Taneja; Liliya Benchetrit; Peter Makusha; Robert L McNamara; Alexander B Pine
Journal:  J Investig Med High Impact Case Rep       Date:  2018-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.